ICD Code D69.3

ICD code D69.3 is a classification used to identify Immune Thrombocytopenic Purpura (ITP), a condition characterized by a low platelet count due to the immune system mistakenly attacking and destroying platelets. This can lead to easy or excessive bruising and bleeding, as platelets are essential for blood clotting.

1. Thrombocytopenia: A confirmed low platelet count, typically below 100,000 platelets per microliter of blood, as determined by a complete blood count (CBC) test.

2. Purpura: The presence of purpura, which are small, purple spots on the skin caused by bleeding underneath, often observed on the extremities or mucous membranes.

3. Bleeding Symptoms: Evidence of abnormal bleeding, such as frequent nosebleeds, prolonged bleeding from cuts, or excessive menstrual bleeding.

4. Exclusion of Other Causes: Ruling out other potential causes of thrombocytopenia, such as medication side effects, infections, or other hematological disorders, through comprehensive medical history and additional diagnostic tests.

5. Bone Marrow Examination: If necessary, a bone marrow biopsy may be conducted to exclude other hematological conditions and confirm increased megakaryocytes, which are indicative of increased platelet production.

6. Autoimmune Indicators: Presence of autoimmune markers or a history of autoimmune disorders, which may support the diagnosis of an immune-mediated process.

7. Response to Treatment: Observing the patient's response to treatments typically used for immune thrombocytopenic purpura, such as corticosteroids or intravenous immunoglobulin (IVIG), can further confirm the diagnosis.

8. Chronicity: For chronic cases, the persistence of symptoms and low platelet count for more than 12 months despite treatment efforts.

For the ICD code D69.3, which pertains to Immune Thrombocytopenic Purpura, the relevant CPT codes that may be applicable for treatment and management include:

1. CPT 36415 - Collection of venous blood by venipuncture.
2. CPT 85025 - Complete blood count (CBC) with automated differential white blood cell count.
3. CPT 85027 - Complete blood count (CBC), automated (Hgb, Hct, RBC, WBC, and platelet count).
4. CPT 86021 - Antibody identification; platelet.
5. CPT 96365 - Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour.
6. CPT 96366 - Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour.
7. CPT 96401 - Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic.
8. CPT 96413 - Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug.
9. CPT 96415 - Chemotherapy administration, intravenous infusion technique; each additional hour.
10. CPT 96417 - Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour.

These CPT codes are commonly associated with the diagnostic and therapeutic procedures that may be involved in the management of patients with Immune Thrombocytopenic Purpura. It is important for healthcare providers to verify the specific services rendered and ensure accurate coding for optimal reimbursement and compliance.

Discover how MD Clarity's RevFind software can enhance your revenue cycle management by accurately reading your contracts and detecting underpayments for CPT codes associated with ICD code D69.3. Schedule a demo today to see how RevFind can help ensure you're receiving the full reimbursement you deserve.